Rozprawy doktorskie na temat „Antidepressant medication”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 36 najlepszych rozpraw doktorskich naukowych na temat „Antidepressant medication”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj rozprawy doktorskie z różnych dziedzin i twórz odpowiednie bibliografie.
Åkerblad, Ann-Charlotte. "Adherence to Antidepressant Medication". Doctoral thesis, Uppsala University, Department of Neuroscience, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7769.
Pełny tekst źródłaNon-adherence to medication is a major obstacle in the treatment of depression. The objectives of the present study were to explore the effect of two interventions aiming to increase antidepressant treatment adherence, and to examine long-term consequences and costs of depression in adherent and non-adherent primary care patients.
A randomised controlled design was used to assess the respective effects of a written educational adherence enhancing programme and therapeutic drug monitoring in patients with major depression treated with sertraline for 24 weeks. All patients were prospectively followed during two years.
Treatment adherence was found in 41% of the 1031 included patients. None of the interventions resulted in a significant increase in adherence rate. However, significantly more patients in the group receiving the written educational material had responded at week 24 as compared to patients in the control group.
The overall remission rate after two years was 68%. In total, 34% of the responders experienced at least one relapse. Response and remission rates at week 24, year 1 and year 2 were significantly higher in adherent as compared to non-adherent patients. No relationship between adherence and relapse rate was seen.
The mean total cost per patient during two years was KSEK 363 whereof indirect costs represented 87%. No significant differences in costs between intervention groups or between adherent and non-adherent patients could be demonstrated. However, the mean cost per patient was 39% lower for treatment responders as compared to non-responders.
Non-adherence was predicted by age below 35 or above 64 years, no concomitant medications, personality disorder, sensation seeking personality traits and substance abuse.
The results indicate a strong positive relationship between treatment adherence and clinical outcome. In addition, the study shows that depression is a costly disease and that certain patient characteristics predict non-adherence.
Åkerblad, Ann-Charlotte. "Adherence to antidepressant medication /". Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7769.
Pełny tekst źródłaCotterchio, Michelle. "Antidepressant medication use and breast cancer risk". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0007/NQ41131.pdf.
Pełny tekst źródłaGallagher, Shawn Patrick, i Shawn Patrick Gallagher. "Antidepressant Medication Adherence in Active Duty Army Soldiers". Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/626157.
Pełny tekst źródłaLinton, Pamela. "Correlates of Antidepressant Medication Compliance Use Among Depressed Women". DigitalCommons@USU, 2001. https://digitalcommons.usu.edu/etd/2537.
Pełny tekst źródłaSaad, Mysa. "Characteristics of Cardiorespiratory Function During Sleep Related to Depression and Antidepressant Medication Use". Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39417.
Pełny tekst źródłaDimidjian, Sona. "Behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of major depression /". Thesis, Connect to this title online; UW restricted, 2005. http://hdl.handle.net/1773/9064.
Pełny tekst źródłaWeaver, Alice. "'Journeys through depression' : patients' experiences of transformational change through mindfulness based cognitive therapy (MBCT) and antidepressant medication (ADM)". Thesis, University of Exeter, 2015. http://hdl.handle.net/10871/18309.
Pełny tekst źródłaHolland, Kate E., i n/a. "Conformity and resistance: Discursive struggles in the Australian mental health field". University of Canberra. Communication, 2007. http://erl.canberra.edu.au./public/adt-AUC20081022.153830.
Pełny tekst źródłaChabenat, Apolline. "Alteration of camouflage and behaviour in two marine invertebrates, Sepia officinalis and Carcinus maenas, by antidepressant medication Hidden in the sand: Alteration of burying behaviour in shore crabs and cuttlefish by antidepressant exposure". Thesis, Normandie, 2020. http://www.theses.fr/2020NORMLH15.
Pełny tekst źródłaJuveniles of the common cuttlefish, Sepia officinalis, and the green shore crab, Carcinus maenas, develop themselves in the intertidal zone and coastal waters impacted by continental pollution such as pharmaceutical residues. This research focused on the effects two antidepressants, the fluoxetine and the venlafaxine, on the camouflage and behaviour of cuttlefish and shore crabs. Both molecules are worrying because they are designed to act on serotonergic system and are commonly detected in aquatic environments. Thus, to approach realistic scenario of exposure fluoxetine was either combined or not with venlafaxine. The results show significant effects of antidepressants at environmentally realistic concentrations, especially the combination of fluoxetine and venlafaxine, on sensitive endpoints such as burying behaviour, colour change and background matching, locomotor activity in crabs and predatory behaviour in cuttlefish. Furthermore, the exposure to antidepressants at early development stage seems to alter maturation and/or learning processes in cuttlefish. Overall, these studies demonstrated the need to investigate further with low range concentrations on key behaviours of non-target species
Ryan, Elizabeth. "The Therapeutic Alliance in Cognitive Therapy for Depression in Combination with Antidepressant Medication: Relations to Subsequent Symptom Change and Treatment Retention". The Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=osu1262278719.
Pełny tekst źródłaBoudreau, Denise M. "The association between HMG-CoA inhibitor use and breast cancer risk & a validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use /". Thesis, Connect to this title online; UW restricted, 2002. http://hdl.handle.net/1773/7934.
Pełny tekst źródłaAshbury, Janet E. "Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study". Thesis, Kingston, Ont. : [s.n.], 2008. http://hdl.handle.net/1974/971.
Pełny tekst źródłaFulton-Kehoe, Deborah. "Use of antidepressant medications in relation to the incidence of breast cancer /". Thesis, Connect to this title online; UW restricted, 2005. http://hdl.handle.net/1773/10941.
Pełny tekst źródłaWilson, Susan Jenifer. "The effect of psychotropic medication on sleep and daytime sleepiness in volunteers and depressed patients". Thesis, University of Bristol, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.297973.
Pełny tekst źródłaSekar, Sakthivel. "Investigation of Neuronal Effects of Anxiogenic and Antidepressant Medications using Pharmacological Magnetic Resonance Imaging". Thesis, University of Newcastle Upon Tyne, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.519474.
Pełny tekst źródłaGribbin, Jonathan. "Falls in older people and the role of commonly prescribed antidepressant and antihypertensive medications". Thesis, University of Nottingham, 2013. http://eprints.nottingham.ac.uk/28451/.
Pełny tekst źródłaCui, Ling 1978. "A comparative study of the diffusion of antihypertensive and antidepressant medications in Germany in Japan". Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/32283.
Pełny tekst źródłaIncludes bibliographical references (p. 137-141).
This thesis analyzes and compares the diffusion of antihypertensive and antidepressant medications in Germany and Japan during the time period of 1992 and 2003. The antihypertensive medications are classified as new, middle and old generations and the antidepressants are classified as new and old generations in this study. The demographic, economic, price, promotional, regulatory, and cultural factors that contributed to the sales level, number of compounds available in the market, and launch time of these medications are also examined using quantitative and qualitative methods at therapeutic class, generation, as well as product levels. The qualitative analysis includes discussions on the general health care systems, health care polices, and country-specific hypertension- and depression-related cultural backgrounds. Econometric tools (descriptive statistics and linear regression models) are used as means of quantitative analysis. The diffusion of different generations of medications is examined. The degree of the use of branded vs. generic medications are also compared. Finally, Chow-tests are conducted for cross-country and cross- therapeutic-class comparisons. This study finds that there are significant branded-v-generic, cross-generation, cross- class, cross-country differences in the diffusion of the selected therapeutic classes in the two countries. The factors examined contributed to the diffusion to various extents. Among which, the cultural factor played an important role in the adoption and sales of new medications of both therapeutic classes in both countries, especially the antidepressants in Japan. The promotional factors appear not to be very significant in the sales volumes, partially due to the regulatory settings of the two national-based health care systems.
y Ling Cui.
S.M.
Fitton, Catherine Alexandra. "Identifying adverse outcomes in neonates and children following in utero exposure to medication". Thesis, University of Aberdeen, 2019. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=240861.
Pełny tekst źródłaGhanem, Simon. "Inflammation in young Swedish men and risk of adult-onset depression defined by prescription of antidepressant medications". Thesis, Örebro universitet, Institutionen för medicinska vetenskaper, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-86370.
Pełny tekst źródłaLöppönen, P. (Pekka). "Preceding medication, inflammation, and hematoma evacuation predict outcome of intracerebral hemorrhage:a population based study". Doctoral thesis, Oulun yliopisto, 2016. http://urn.fi/urn:isbn:9789526211282.
Pełny tekst źródłaTiivistelmä Primääri aivoverenvuoto (pICH) on vakava, yhtäkkisesti alkava sairaus, johon liittyy korkea kuolleisuus ja vaikea vammautuminen. Parantavan hoidon puuttuessa on hoito lähinnä elintoimintoja tukevaa vuodon laajenemisen ja komplikaatioiden estämistä. Ennusteeseen vaikuttavien tekijöiden parempi tunteminen on ehto tehokkaiden hoitojen löytämiseksi. Väitöskirjatutkimustani varten kerättiin Oulun yliopistollisen sairaalan alueelta vuosien 1993-2008 aikana 982 aivoverenvuotoon sairastuneen potilaan väestöpohjainen aineisto. Tutkimus osoitti, että varfariinin ja selektiivisen serotoniinin takaisinoton estäjän (SSRI) yhteiskäyttö aivoverenvuodon aikana lisäsi kuolevuutta pelkkään varfariiniin nähden. Alkuvaiheen koholla oleva C-reaktiivinen proteiini oli itsenäinen aivoverenvuodon jälkeistä vammautuneisuutta ennustava tekijä. Yhteys ei selittynyt olemassa olevalla sydänsairaudella, diabeteksella, aivoverenvuodon vaikeudella tai infektioilla. Kirurginen aivoverenvuodon poistoleikkaus paransi kolmen kuukauden ennustetta verrattuna potilaisiin ilman leikkausta. Erityisesti leikkaus auttoi alle 70-vuotiaita potilaita, joilla oli yli 30 millilitran kokoinen pinnallisempi vuoto. Leikkaus ei parantanut fyysistä kuntoutumista. Aiempi sairastettu aivoinfarkti oli itsenäinen aivoverenvuodon uusiutumista ennustava tekijä. Diabetes saattaa lisätä ja hoidossa oleva verenpainetauti laskea riskiä tappavaan uusintavuotoon. Aspiriinin tai SSRI:n käyttö eivät lisänneet uusintavuodon riskiä
Dublin, Sascha. "Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other medications acting on the central nervous system /". Thesis, Connect to this title online; UW restricted, 1999. http://hdl.handle.net/1773/10861.
Pełny tekst źródłaRissanen, I. (Ina). "Nervous system medications and suicidal ideation and behaviour:the Northern Finland Birth Cohort 1966". Doctoral thesis, Oulun yliopisto, 2015. http://urn.fi/urn:isbn:9789526208077.
Pełny tekst źródłaTiivistelmä Tämän väitöstutkimuksen tarkoituksena oli tutkia hermostoon vaikuttavien lääkkeiden, lähinnä psykoosilääkkeiden, masennuslääkkeiden, bentsodiatsepiinien sekä epilepsialääkkeiden, yhteyttä itsetuhoisiin ajatuksiin, itsemurhayrityksiin ja itsemurhiin. Aihetta tutkittiin eri diagnoosiluokissa suuressa väestöaineistossa, Pohjois-Suomen vuoden 1966 syntymäkohortissa. Tieto tutkimushenkilöiden lääkkeenkäytöstä vuodelta 1997 kerättiin Kelan lääkeostorekisteristä sekä postikyselyn avulla. Itsetuhoisten ajatusten ja muiden masennus- ja ahdistusoireiden vakavuutta mitattiin Hopkins Symptom Checklist-25 -kyselyn avulla vuonna 1997. Tieto itsemurhista kerättiin 15 vuoden seurannassa kuolinsyyrekisteristä ja tieto itsemurhayrityksistä hoitoilmoitusrekisteristä. Psykoosilääkkeiden, masennuslääkkeiden ja bentsodiatsepiinien käyttö oli yhteydessä lisääntyneisiin itsetuhoisiin ajatuksiin, itsemurhayrityksiin ja itsemurhiin. Epilepsialääkkeet eivät liittyneet itsetuhoisuuteen. Usean hermostoon vaikuttavan lääkkeen yhtäaikainen käyttö oli yhteydessä lisääntyneeseen itsetuhoisuuteen. Kaikki hermostoon vaikuttavat lääkkeet liittyivät lisääntyneisiin masennus- ja ahdistusoireisiin. Kun lääkityksen yhteys masennus- ja ahdistusoireisiin otettiin huomioon, lääkkeet eivät olleet erityisesti yhteydessä itsetuhoisiin ajatuksiin. Diagnostisten ryhmien välillä ei ollut eroa hermostoon vaikuttavien lääkkeiden ja itsemurhayritysten tai itsemurhien välisessä yhteydessä. Henkilöillä, joilla ei ole psykoosia, suuremmat psykoosilääkeannokset olivat yhteydessä itsetuhoisten ajatusten vakavuuteen kun muiden masennus- ja ahdistusoireiden vakavuus otettiin huomioon. Unettomuudesta kärsivillä henkilöillä masennuslääkkeen käyttö oli liittyi lisääntyneisiin itsetuhoisiin ajatuksiin kun muut oireet huomioitiin. Hermostoon vaikuttavat lääkkeet ovat yhteydessä lisääntyneisiin itsetuhoisiin ajatuksiin, mutta ne ovat myös vahvasti yhteydessä muihin masennus- ja ahdistusoireisiin. Tietyt henkilöt voivat kuitenkin olla erityisen herkkiä nimenomaan itsetuhoisille ajatuksille, ja heitä tulisi seurata erityisen tiiviisti. Tällaisia ovat henkilöt, joilla ei ole psykoosia, mutta jotka käyttävät suuria psykoosilääkeannoksia, sekä vakavasta unettomuudesta kärsivät henkilöt, jotka käyttävät masennuslääkettä
Hulkko, A. (Anja). "The association of lifetime antipsychotic and other psychiatric medications with cognition in schizophrenia:the Northern Finland Birth Cohort 1966 Study". Doctoral thesis, Oulun yliopisto, 2017. http://urn.fi/urn:isbn:9789526216836.
Pełny tekst źródłaTiivistelmä Psykoosilääkitys on skitsofrenian pitkäaikaisen, jopa elinikäisen hoidon perusta. Useiden psykoosilääkkeiden yhtäaikaiskäyttö ja muiden psyykenlääkkeiden oheiskäyttö ovat yleisiä hoitostrategioita. Psyykenlääkkeiden pitkäaikaisvaikutuksia etenkin kognitioon skitsofreniassa tunnetaan huonosti. Kognitiiviset puutokset ovat keskeinen, elinaikaisesti pysyvä skitsofrenian oirepiirre ja merkittävimpiä ennustetekijöitä. Tämän naturalistisen tutkimuksen tavoite oli analysoida elinaikaisen psykoosi-, bentsodiatsepiini- ja masennuslääkealtistuksen sekä elinaikaisten psykoosilääkkeiden käytön trendien yhteyttä kognitioon varhaisessa keski-iässä skitsofreniassa. Ei-psykoottiset verrokit toimivat normatiivisen kognitiivisen suorituskyvyn vertailuryhmänä. Tutkimusaineisto koostui Pohjois-Suomen vuoden 1966 syntymäkohorttiin kuuluvista 40 ja 60 henkilöstä, joilla oli skitsofrenia, sekä 73 ja 191 ei-psykoottisesta verrokista. Tiedot psyykenlääkkeiden elinaikaiskäytöstä kerättiin sairauskertomuksista, rekistereistä ja haastatteluista, ja ne yhdistettiin 34 ja 43 vuoden iässä tehtyihin laajoihin psykiatrisiin ja neuropsykologisiin tutkimuksiin. Korkeampi kumulatiivinen elinaikainen psykoosilääkealtistus oli yhteydessä heikompaan kielelliseen muisti- ja oppimissuoriutumiseen 34-vuotiaana ja sen suurempaan laskuun 34 ja 43 ikävuoden välillä sekä heikompaan kognitioon 43-vuotiaana skitsofreniassa. Suhteellisen pitkä psykoosilääketauko ennen neuropsykologista tutkimusta oli yhteydessä parempaan kognitioon 43-vuotiaana. Muut elinaikaisen psykoosilääkityksen käytön trendit, psykoosilääkkeiden yhtäaikaiskäyttö tai elinaikainen kumulatiivinen bentsodiatsepiini- tai masennuslääkealtistus eivät olleet yhteydessä kognitioon. Tämä naturalistinen tutkimus kuvasi ensimmäisenä yhteyden suuremman kumulatiivisen elinaikaisen psykoosilääkealtistuksen ja heikomman kognition välillä varhaisessa keski-iässä skitsofreniassa. Muiden psyykenlääkkeiden käyttö tai sairauteen liittyvät tekijät eivät näyttäneet sekoittavan tätä yhteyttä. Vaikka on mahdollista, että kaikkia sekoittavia tekijöitä ei pystytty huomioimaan, tulosten perusteella korkea-annoksinen, pitkäaikainen psykoosilääkitys saattaa vaikuttaa skitsofrenian taudinkulkuun heikentämällä kognitiivista toipumista. Lisätutkimusta psyykenlääkityksen pitkäaikaisvaikutuksista tarvitaan skitsofrenian turvallisen ja tehokkaan hoidon kehittämiseksi
Lundin, Cecilia. "Antidepressant medication and previous or current depression and anxiety disorder: implications on healthcare utilization among pregnant women". Thesis, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-210471.
Pełny tekst źródłaFoley, Christine Marie. "Comparison And Application Of Methods To Address Confounding By Indication In Non-Randomized Clinical Studies". 2013. https://scholarworks.umass.edu/theses/1121.
Pełny tekst źródłaAssayag, Jonathan. "Impact of type of drug insurance on adherence, persistence and costs of antidepressant drugs : a Quebec population-based study". Thèse, 2012. http://hdl.handle.net/1866/8557.
Pełny tekst źródłaBackground: The influence of the type of drug insurance on adherence, persistence and cost of antidepressants is not well known. Objective: To compare adherence, persistence and cost of antidepressants in patients with private and public drug insurance. Research Design: A matched cohort study was conducted using prescription claims databases from Quebec, Canada. Subjects: 194 privately and 1923 publicly insured patients (18-64 years) who filled at least one prescription for an antidepressant between December 2007 and September 2009. Measures: Adherence over one year was estimated using the proportion of prescribed days covered (PPDC). The difference in mean PPDC between patients with private and public drug insurance was estimated with a linear regression model. Persistence was compared between the groups with a Cox regression model, and the monthly cost of antidepressants (CAD$) was compared between the two groups using linear regression. Results: The PPDC was 86.4% (95% CI: 83.3-89.5) in patients with private and 81.3% (95%CI: 80.1-82.5) in patients with public drug insurance and the adjusted mean difference was 6.7% (95% CI: 3.0-10.4). Persistence was 49.5% in patients with private and 18.9% in patients with public drug insurance at one year (p<0.001), and the adjusted hazard ratio was 0.48 (95%CI: 0.30-0.76). Patients privately insured paid 14.94$ CAD (95% CI: 12.30; 17.58) more per month on average for their antidepressants. Conclusion: Better adherence and persistence and higher costs were observed in privately insured patients. Cost difference might be due to different pharmacy payment requirements and pharmacists’ honorary restrictions under the public plan.
Taljaard, Lian. "Adherence to antidepressants in psychiatry: a descriptive survey of outpatients in Johannesburg, Gauteng". Diss., 2016. http://hdl.handle.net/10500/21169.
Pełny tekst źródłaPharmacological treatment is often required in the management of psychiatric disorders. Non-adherence to medication represents a significant health concern that prevents patients from fully benefitting from their treatment, and can lead to negative consequences for individuals, their families and the healthcare system. The adherence rates to antidepressant medications in a sample of psychiatric outpatients in the Johannesburg Metropolitan district of Gauteng Province were examined. A descriptive survey method was employed to systematically collect data from n=377 patients using a structured, non-clinical questionnaire and the 8-item Morisky Medication Adherence Questionnaire. Variables were analysed using descriptive and correlational statistical methods. Antidepressant adherence rates were reported as 47.7% (low), 31.3% (medium) and 21% (high). These high rates represent a concern in antidepressant treatment, and health care practitioners and health systems must take this into consideration when planning and developing interventions to improve adherence in this area. The current study found significant correlations between antidepressant adherence rates and some medication-, health system- and moderating variables. Based on these findings, interventions that provide appropriate health-related education about treatment and improved social support systems may be effective in addressing antidepressant non-adherence in psychiatric outpatients in this region.
Psychology
M. Soc.Sc. (Psychology)
Lorenz, Tierney Kyle Ahrold. "Efficacy of an exercise intervention for sexual side effects of antidepressant medications in women". Thesis, 2013. http://hdl.handle.net/2152/26084.
Pełny tekst źródłatext
Stewart, JEREMY. "The Impact of Efficacious Treatments for Major Depressive Disorder on Remission Rates of Specific Symptoms: A Re-Analysis of the Treatment of Depression Collaborative Research Program". Thesis, 2009. http://hdl.handle.net/1974/5121.
Pełny tekst źródłaThesis (Master, Psychology) -- Queen's University, 2009-09-03 14:41:46.163
TSENG, MEI-CHU, i 曾美菊. "Duplicate Medication of Antidepressants and Hypnotics in Outpatient Department of a Northern Taiwan Medical Center : An Epidemiologic Study". Thesis, 2016. http://ndltd.ncl.edu.tw/handle/fs43qg.
Pełny tekst źródła國防醫學院
公共衛生學研究所
104
Objective : The prevalence of major depression and chronic insomnia in Taiwan is increasing with social changes and lifestyle modernization. Our study evaluated the frequency of duplicate hypnotic and antidepressant medication and the factors affecting it, by analyzing data extracted from outpatient department (OPD) of a medical center in northern Taiwan. Methods : Data is extracted from the 2015 OPD records of a medical center in northern Taiwan. The National Health Insurance (NHI) Pharmaceutical Subsidy Anatomical Therapeutic Chemical (ATC) classification system was used to extract the pharmaceutical classification records. The cases included were then divided into 3 subgroups: patients taking antidepressants, patients taking hypnotics, and patients taking both antidepressants and hypnotics. In each subgroup we compare the demography, medical seeking behavior and clinical data between patients receive or do not receive duplicate medication. These data was analyzed by SPSS version 20.0 calculating percentage, average, standard deviation, chi-square test and independent-samples t test, to describe the epidemiologic characteristics. Logistic regression was applied to evaluate the factors affecting duplicate medication, and p value <0.05 was considered significant. Result : Total case number was 28,389 and 28.91% of them have received duplicate medication. 59.20% are female, and most of them aged between 60 to 69 years old (23.19%), with second most aged between 50 to 59 years old (19.67%). The average number of OPD visit is 9.6. 92.83% of the patients received prescription for 28-day medication, and 16.62% have elevated serum creatinine concentration. Conclusion : The common factor of duplicate medication in the three subgroups of our study is the increased number of OPD visit. Therefore we suggest establishing correct medical seeking behavior and medication safety recognition, decreasing the frequency of OPD visit to reduce the incidence of duplicate medication. Key words : antidepressant, hypnotic, duplicate medication, inappropriate prescription
Samba, Dawda. "Availability of psychotropic medications in primary health care facilities in the Gambia". Master's thesis, 2017. http://hdl.handle.net/10362/24319.
Pełny tekst źródłaRESUMO: Antecedentes: A medicação é um componente significativo na implementação do mhGAP na Gâmbia. Há uma crescente ênfase no fortalecimento dos sistemas de saúde na Gâmbia e na preparação das instalações para oferecer serviços de saúde mental acessíveis, custo-acessíveis, aceitáveis e de qualidade. Objetivo: Avaliar a disponibilidade de medicamentos psicotrópicos essenciais em instalações de Cuidados de Saúde Primários (CSP) e identificar facilitadores / barreiras à sua disponibilidade. Desenho: Foi utilizado um questionário adaptado da Lista de Medicamentos Essenciais da OMS de 2015 para avaliar a disponibilidade dos medicamentos psicotrópicos do núcleo. Definição: 106 instalações foram avaliadas nos três níveis através dos quais os CSP são fornecidos na Gâmbia; os níveis primário, secundário e terciário, que fazem parte dos Hospitais, maiores ou menores organizações de saúde, Postos de saúde da aldeia, ONGs e Clínicas Privadas e Principais Cadeias the Farmácia. Resultados: A disponibilidade nacional de medicamentos psicotrópicos é de 30%, com disponibilidade de 27,7% em instalações públicas, em comparação com 32,8% em instalações privadas. Os custos mensais do tratamento variaram de US $ 10,7 para Midazolam (15 mg por dia) para US $ 5 para Carbamazepina (200 mg por dia). 1% das instalações possuem um especialista psiquiátrico (2 psiquiatras cubanos de assistência técnica e 8 enfermeiras psiquiátricas gambianas). Em 14% das instalações, os enfermeiros auxiliares (não treinados) prescrevem medicamentos psicotrópicos. Em alguns casos, a compra de um único medicamento antidepressivo pode alcançar até 28% de um salário mensal. Conclusão: A disponibilidade de medicamentos psicotrópicos é baixa em todas as regiões da Gâmbia e a diferença / disparidade entre a disponibilidade do setor público e privado é muito evidente. A baixa disponibilidade e o alto custo dos tratamentos psiquiátricos, representam obstáculos significativos para o atendimento do paciente e não correspondem ao peso real dos problemas mentais e de abuso substância em 6,5% da população adulta. Os preços dos medicamentos do setor privado são exorbitantes considerando o poder médio de ganho de um funcionário gambiano.
Ponte, Pedro do Rego. "Relationship between preoperative antidepressant and antianxiety medications and postoperative hospital length of stay: A retrospective study on abdominal hysterectomy patients". Dissertação, 2020. https://hdl.handle.net/10216/128322.
Pełny tekst źródłaPonte, Pedro do Rego. "Relationship between preoperative antidepressant and antianxiety medications and postoperative hospital length of stay: A retrospective study on abdominal hysterectomy patients". Master's thesis, 2020. https://hdl.handle.net/10216/128322.
Pełny tekst źródłaChen, Hua. "The economic and clinical impacts of prescribing antidepressant, antconvulsant and antipsychotic medications off-label for patients with schizophrenia, bipolar disorders, depression and anxiety". 2005. http://purl.galileo.usg.edu/uga%5Fetd/chen%5Fhua%5F200508%5Fphd.
Pełny tekst źródłaRiley, Nicole Marie. "Injuries Among Elderly Canadians: Psychotropic Medications and the Impact of Alcohol". Thesis, 2011. http://hdl.handle.net/1807/31918.
Pełny tekst źródła